Ketoconazole in the treatment of eumycetoma due to Madurella mycetomii.
暂无分享，去创建一个
[1] G. Sarosi,et al. Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study. , 2020, Annals of internal medicine.
[2] B. Dupont,et al. Laboratory and clinical assessment of ketoconazole in deep-seated mycoses. , 1983, The American journal of medicine.
[3] R. Hay. Ketoconazole in the treatment of fungal infection. Clinical and laboratory studies. , 1983, The American journal of medicine.
[4] E. Svejgaard,et al. Toxic hepatis during ketoconazole treatment. , 1981, British medical journal.
[5] L. C. Cucé,et al. Treatment of Paracoccidioidomycosis, Candidiasis, Chromomycosis, Lobomycosis, and Mycetoma with Ketoconazole , 1980, International journal of dermatology.
[6] V. Schuermans,et al. An evaluation of two years of clinical experience with ketoconazole. , 1980, Reviews of infectious diseases.
[7] E. Mahgoub. Medical management of mycetoma. , 1976, Bulletin of the World Health Organization.